Sector Update: Health Care Stocks Fall Late Afternoon
Grifols Among Companies to Face Spanish Regulator's Disciplinary Proceedings
CNMV Initiates Disciplinary Proceedings Against Grifols, Gotham, GIP
Snowflake, Hawaiian Electric Industries And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Grifols Advances Leadership Transition, Strengthens Governance
Sharp Sword! The FTC sues three major pharmaceutical 'middlemen', vowing to correct the distorted chain of interests.
①The USA FTC announced on its official website that it has filed a lawsuit against three major pharmaceutical benefit managers and their affiliated organizations, accusing them of engaging in anti-competitive and unfair rebate practices; ② The FTC also "explicitly stated" in the declaration that it is deeply concerned about the roles played by Eli Lilly, Novo-Nordisk, and Sanofi, insulin pharmaceutical companies, and may suggest in future enforcement actions to prosecute these pharmaceutical manufacturers.
Significant Shareholders Exercise Right to Grifols Board Seat
Market Chatter: Grifols Seeking Consultants to Fend off Shareholder Challenge
Shanghai RAAS (002252.SZ): It is expected that the annual trade related to Grifols globally in 2024 will be approximately $0.562 billion.
On September 13, 2024, Shanghai Raas (002252.SZ) received a specific object investigation and was asked about the situation of the company's agency of Grifols albumin. The company stated that in the first half of 2024, the amount of daily related transactions between the company and Grifols Global, a subsidiary of Grifols, for the agency of human albumin products, was $0.231 billion. The company expects the total amount of daily related transactions with Grifols Global in 2024 to be approximately $0.562 billion.
Top Gap Ups and Downs on Wednesday: NVS, HUM, WIT and More
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading
Grifols Egypt Collaborates With Orange Business to Deliver New Data Center and Communications Infrastructure, Supporting Advanced Medical Processes
Advanced Infusion Care (AIC) Announces New Hire to Trade & Procurement Team
Grifols Class B Stock Falls as Brookfield Reportedly Seeks Lower Price
Sector Update: Health Care Stocks Rise in Afternoon Trading
Market Chatter: Brookfield in Talks With Sovereign Funds to Join Grifols Acquisition Bid
Express News | Brookfield In Talks With Sovereign Funds To Join Grifols Bid
Biotest Chief Scientific Officer to Step Down
This Reviled Pharmaceutical Firm Holds Promise of a Healthier Future -- Heard on the Street -- WSJ
Lucid, Grifols And Amer Sports Are Among Top 8 Mid Cap Stock Gainers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?